Bavarian Nordic eyes opportunities in huge pox vaccine stockpiles
Several countries are currently sitting on hundreds of millions of second-generation pox vaccines in case of biological terror attacks. But people do not accept the side effects, says the CEO of Bavarian Nordic, who wants to push the company’s pox vaccine into a leading position at these emergency stores.
by christian bundgaard, translated by catherine brett
Since 2007, the Strategic National Stockpile (SNS) has stockpiled enough pox vaccines to vaccinate every single person in the US if a biological terror attack occurs. The UK has done the same.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Analyst spots more monkeypox opportunities for Bavarian
For subscribers
.jpg)
.jpg)
.jpg&w=384&q=75)
